Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,447 total articles

BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th

BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th

BIO-key International announced participation in a government-sponsored cybersecurity workshop hosted by the Association of Banks in Jordan on July 6th. The event focuses on enhancing banking sector defenses against evolving cyber threats using BIO-key's biometric identity and access management solutions. This engagement highlights BIO-key's commit…

Symbotic Announces Acquisition of ARMS Innovations, Advancing a New Era of Warehouse Operations Optimization

Symbotic Announces Acquisition of ARMS Innovations, Advancing a New Era of Warehouse Operations Optimization

Symbotic Inc., a U.S.-based leader in AI-powered robotics for supply chains, announced the acquisition of UK-based ARMS Innovations, enhancing its system from automation execution to full-scale warehouse operations optimization. This strategic acquisition enables Symbotic to offer a unified AI-driven operational platform that integrates automated s…

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Abivax SA has announced that the underwriters for its recent offering have fully exercised their option to purchase an additional 960,000 American Depositary Shares (ADSs). This results in gross proceeds of approximately $920 million. The funds will primarily be used to support potential commercialization of its lead drug candidate, obefazimod, in …

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Molecular Partners AG, a clinical-stage biotech company listed on NASDAQ and SIX, together with Orano Med, announced dosing of the first patients in the US Phase 1/2a clinical trial of MP0712, a DLL3-targeting Radio-DARPin therapeutic labeled with lead-212. Targeting DLL3, highly expressed in small cell lung cancer and neuroendocrine tumors, MP0712…

Guest Supply Signs Asia-Pacific Licensing Agreement with HAAN

Guest Supply Signs Asia-Pacific Licensing Agreement with HAAN

Guest Supply, part of Sysco Corporation, has entered into a licensing agreement with HAAN to manufacture and distribute HAAN-branded personal care products across Asia Pacific hotels. The partnership leverages HAAN's refillable, travel-centric, clean personal care products and Guest Supply's manufacturing and distribution expertise to enhance hospi…

FDA Alignment to Advance ProstACT Global Phase 3 Trial

FDA Alignment to Advance ProstACT Global Phase 3 Trial

Telix Pharmaceuticals announced that the U.S. FDA has agreed on the clinical protocol and statistical framework to proceed with Part 2 of the ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration resistant prostate cancer. The FDA confirmed safety data from Part 1 is sufficient to initiate Part 2 in the U.S., enabling international e…

Columbia Financial, Inc. Announces Receipt of Stockholder and Depositor Approvals of Pending Second Step Conversion and Updated Results of Subscription Offering

Columbia Financial, Inc. Announces Receipt of Stockholder and Depositor Approvals of Pending Second Step Conversion and Updated Results of Subscription Offering

Columbia Financial, Inc. announced that its stockholders and depositors have approved its plan for a second step conversion from mutual to fully public stock holding company and its acquisition of Northfield Bancorp, Inc. The company raised approximately $1.1 billion in a subscription offering and plans a firm commitment underwritten offering to co…

PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry

PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry

Dentsply Sirona and PDS Health announced that PDS Health practices have surpassed five million CEREC chairside restorations, underscoring widespread clinician adoption and integration of digital restorative workflows. This milestone reflects efficiency improvements, same-day treatment capabilities, and enhanced patient care driven by connected dent…

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Has Completed Its Acquisition of Riverbend Mineral and Royalty Interests

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Has Completed Its Acquisition of Riverbend Mineral and Royalty Interests

Viper Energy, Inc., a subsidiary of Diamondback Energy, has finalized its acquisition of all equity interests in Riverbend Oil & Gas IX, LLC for $337 million in cash and approximately 3.7 million shares. This acquisition expands Viper's holdings in oil and natural gas mineral and royalty interests primarily in the Permian Basin, funded by cash and …

XAI Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

XAI Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

XAI Floating Rate & Alternative Income Trust announced its regular monthly distribution of $0.225 per common share, payable on August 3, 2026, with no change from the previous month's distribution. The Trust aims to maintain stable monthly distributions despite fluctuations in net investment income and capital gains, investing primarily in floating…

ARMOUR Residential REIT, Inc. Confirms July 2026 Common Share and Q3 2026 Series C Preferred Share Dividends

ARMOUR Residential REIT, Inc. Confirms July 2026 Common Share and Q3 2026 Series C Preferred Share Dividends

ARMOUR Residential REIT, Inc. confirms its July 2026 monthly cash dividend of $0.24 per common share and the Q3 2026 monthly cash dividend rate of approximately $0.14583 per Series C preferred share consistent with prior guidance. The company remains compliant with REIT tax distribution requirements while maintaining focus on its mortgage-backed se…